List of bibliographic references
Number of relevant bibliographic references: 7.
List of associated KwdEn.i
Nombre de documents | Descripteur |
5 | Female |
5 | Humans |
5 | Male |
5 | Middle Aged |
4 | Genotype |
3 | Adult |
3 | Antiviral Agents (therapeutic use) |
3 | Drug Therapy, Combination |
3 | Hepatitis C, Chronic (drug therapy) |
3 | Ribavirin (therapeutic use) |
3 | Treatment Outcome |
2 | Aged |
2 | Antiviral Agents (adverse effects) |
2 | Benzimidazoles (therapeutic use) |
2 | Dose-Response Relationship, Drug |
2 | Drug Administration Schedule |
2 | Hepacivirus (drug effects) |
2 | Hepacivirus (genetics) |
2 | Hepatitis C, Chronic (complications) |
2 | Interferon-alpha (therapeutic use) |
2 | Liver Cirrhosis (drug therapy) |
2 | Oligopeptides (adverse effects) |
2 | Oligopeptides (therapeutic use) |
2 | Polyethylene Glycols (therapeutic use) |
2 | Recombinant Proteins (therapeutic use) |
2 | Ribavirin (adverse effects) |
2 | Young Adult |
1 | Acrylates (adverse effects) |
1 | Acrylates (pharmacology) |
1 | Acrylates (therapeutic use) |
1 | Administration, Oral |
1 | Adolescent |
1 | Aged, 80 and over |
1 | Anemia (diagnosis) |
1 | Anemia (etiology) |
1 | Antiviral Agents (administration & dosage) |
1 | Antiviral Agents (pharmacology) |
1 | Benzimidazoles (adverse effects) |
1 | Benzimidazoles (pharmacology) |
1 | Fatigue (epidemiology) |
1 | Fluorenes (therapeutic use) |
1 | Follow-Up Studies |
1 | Global Health |
1 | Headache (epidemiology) |
1 | Hepacivirus (classification) |
1 | Hepatitis B Surface Antigens (blood) |
1 | Hepatitis B Surface Antigens (drug effects) |
1 | Hepatitis B, Chronic (blood) |
1 | Hepatitis B, Chronic (diagnosis) |
1 | Hepatitis B, Chronic (drug therapy) |
1 | Hepatitis B, Chronic (mortality) |
1 | Hepatitis C (complications) |
1 | Hepatitis C (drug therapy) |
1 | Hepatitis C (virology) |
1 | Hepatitis C, Chronic (blood) |
1 | Hepatitis C, Chronic (mortality) |
1 | Incidence |
1 | Injections, Subcutaneous |
1 | Interferon-alpha (adverse effects) |
1 | Interferons (metabolism) |
1 | Internationality |
1 | Kaplan-Meier Estimate |
1 | Liver Cirrhosis (complications) |
1 | Liver Cirrhosis (mortality) |
1 | Liver Cirrhosis (virology) |
1 | Markov Chains |
1 | Medicine |
1 | Nausea (epidemiology) |
1 | Oligopeptides (administration & dosage) |
1 | Oligopeptides (pharmacology) |
1 | Polyethylene Glycols (adverse effects) |
1 | Polymorphism, Single Nucleotide (genetics) |
1 | Prognosis |
1 | Pyrophosphatases (genetics) |
1 | RNA, Viral |
1 | RNA, Viral (blood) |
1 | Real-Time Polymerase Chain Reaction |
1 | Recombinant Proteins (adverse effects) |
1 | Ribavirin (pharmacology) |
1 | Risk Assessment |
1 | Severity of Illness Index |
1 | Survival Rate |
1 | Tenofovir (therapeutic use) |
1 | Thiazoles (adverse effects) |
1 | Thiazoles (pharmacology) |
1 | Thiazoles (therapeutic use) |
1 | Time Factors |
1 | Typing |
1 | Uridine Monophosphate (analogs & derivatives) |
1 | Uridine Monophosphate (therapeutic use) |
1 | Viral Load |
1 | Viral Load (drug effects) |
1 | Viral hepatitis C |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Allemagne/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/Allemagne/Analysis/Author.i -k "Maria Buti"
HfdIndexSelect -h $EXPLOR_AREA/Data/Allemagne/Analysis/Author.i \
-Sk "Maria Buti" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Allemagne/Analysis/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Allemagne
|étape= Analysis
|type= indexItem
|index= Author.i
|clé= Maria Buti
}}
| This area was generated with Dilib version V0.6.33. Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024 | |